Krystal Biotech Inc expected to post a loss of $1.44 a share - Earnings Preview

Krystal Biotech

05/05/2023 14:34

* Krystal Biotech Inc  KRYS.OQ   KRYS.O  is expected to show
a
rise in quarterly revenue when it reports  results on May 8
(estimated). 
    * The Pittsburgh Pennsylvania-based  company is expected to
report
revenue of $200 thousand, according to the mean estimate from 5
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Krystal Biotech Inc
is
for a loss of $1.44 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Krystal
Biotech
Inc is $108​, above​ its last closing price of $82.18. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -1.31       -1.32      -1.25     Beat    5.4
 Sep. 30 2022  -1.23       -1.22      -1.17     Beat    3.9
 Jun. 30 2022  -0.99       -1.02      -1.10     Missed  -8.3​
 Mar. 31 2022  -1.06       -1.05      -0.99     Beat    5.6
 ​​Dec.        -0.75       -0.73      -0.95     Missed  -29.7
 31 2021                                                
 Sep. 30 2021  -0.76       -0.74      -0.70     Beat    5.2​
 Jun. 30 2021  -0.79       -0.76      -0.74     Beat    2.3
 Mar. 31 2021  -0.54       -0.56      -0.67     Missed  -20.3
 This summary was machine generated May 5 at 13:34 GMT.  All
figures in US dollars  unless otherwise stated